1 / 6
Laboratory Research Material
Tri-Heal
45 mg per vial · Lyophilized powder
Laboratory Research Material
Tri-Heal 45 mg per vial
$249.99
- Blend composition
-
Compound Per vial TB-500 25 mg BPC-157 10 mg KPV 10 mg Total per vial 45 mg - Form
- Lyophilized powder
- Packaging
- 1 × 3 mL vial, boxed
- Shipping
- FedEx 2DayShips from the U.S. Estimated arrival2 business days after dispatchWeekday dispatch · 4 p.m. ET cutoff
Delivery details
Estimated for in-stock orders using FedEx 2Day. Weekends and FedEx closures are excluded. Holiday pickups, destination and carrier delays can affect arrival. Alaska and Hawaii may take longer.
Free U.S. shipping on orders $199+
Important
Research Use Notice
All articles and product information provided on this website are for informational and educational purposes only. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Do not administer these products to humans or animals.
Product Documentation
Details, specifications, and documents
Description
Tri-Heal 45 mg blend
Buy Tri-Heal 45 mg for laboratory research. Each boxed 3 mL vial contains lyophilized powder with three labeled components: TB-500 25 mg, BPC-157 10 mg and KPV 10 mg.
- TB-500: 25 mg per vial
- BPC-157: 10 mg per vial
- KPV: 10 mg per vial
- Total blend: 45 mg per vial
The TB-500 supplied in this product is full-length, N-acetylated thymosin beta-4: a 43-amino-acid peptide identified by CAS 77591-33-4.
How this composition differs
Tri-Heal contains more TB-500 by labeled mass than either of its other ingredients. It differs from the 20 mg BPC-157 + TB-500 blend, which contains equal 10 mg amounts and no KPV. It also contains no GHK-Cu.
The premix fixes the component proportions. For work requiring a separate KPV comparison, see the KPV 10 mg product. A blend name or total milligram value alone is not enough to establish that two products have the same formulation.
Separate the component evidence
In Dalmasso and colleagues’ KPV experiments, peptide transport through PepT1 was associated with reduced inflammatory signaling in stimulated intestinal epithelial and immune-cell models. The paper also examined mouse models; it did not evaluate Tri-Heal.
The BPC-157 tendon-cell study examined migration and survival in rat-derived cells and tissue, rather than this three-component mixture. Meanwhile, analytical TB-500 research identified a seven-residue acetylated fragment in a different preparation. That result concerns the fragment, not the full-length TB-500 component supplied in this blend.
These studies answer different questions. They do not establish a combined response for the 25:10:10 mg formulation. Component controls and blend-specific measurements are needed to distinguish the mixture’s behavior from the behavior of its ingredients.
Check the complete formulation’s records
In COA & Documents, match the product and lot to the original report. Check which of the three components was identified and quantified, and what the reported purity result covers. Total powder weight alone is not a measurement of each peptide’s amount.
The listed milligram values describe composition; 3 mL describes container capacity. For molar calculations, storage or handling decisions, use component identities and instructions applicable to the supplied mixture rather than importing a single ingredient’s specification.
Additional information
| CAS No. | 77591-33-4 (TB‑500), 137525-51-0 (BPC‑157), 67727-97-3 (KPV) |
|---|---|
| Purity | ≥99% |
| Applications | In-vitro assay research, compound characterization, analytical method development |
| Synthesis | Solid-phase synthesis |
| Solubility | Soluble in water or 1% acetic acid |
| Stability & Storage | Stable for up to 24 months at -20°C. |
| Appearance | White lyophilized powder |
| Shipping Conditions | Shipped at ambient temperature; once received, store at -20°C |
| Regulatory/Compliance | Manufactured in a facility that adheres to cGMP guidelines |
| Safety Information | Refer to provided MSDS |
COA & Documents
Independent lot testing
Tri-Heal (TB-500 25mg + BPC-157 10mg + KPV 10mg) Certificate of Analysis
This product has featured batch-specific third-party laboratory documentation. The Pure Lab Peptides summary presents selected source-report fields in a consistent format; the linked original laboratory report controls if any information differs.
- Lot number
- 99712
- Report number
- IF-824-QSA-TR006-BTL26955-42
- Date tested
- July 15, 2026
- Reported purity
- 99.6%
- Labeled content
- 45 mg
Product documents
Product information and laboratory resources. For lot-specific results, use the COA above.
Product & packaging information
Labeled amount, physical form and packaging for Tri-Heal (TB-500 25mg + BPC-157 10mg + KPV 10mg).
Revision 0.4 · 2026-10-05Download PDFLaboratory handling guide
General guidance for applicable lyophilized research materials. Not a product-specific SDS.
Revision 1.0 · 2026-09-22Download PDFGeneral guides & resources
Reading a COA & Verifying Your Lot
PDF · Revision 1.0Receiving, Storage & Traceability Record
PDF · Revision 1.0Research Use & Documentation Scope
PDF · Revision 1.0Need Assistance?
Questions about product documentation?
Contact our support team for help with product records, lot information, orders or certificate verification.
